Business Wire

VOXELJET-AG

Share
voxeljet Unveils New Plastic 3D Printing Process for Higher Quality Results in Investment Casting

voxeljet AG, a leading provider of high-speed, large-format 3D printers and on-demand parts services to industrial and commercial customers, today announced the release of PolyPor C2 (PPC²). PPC² is an advanced PMMA 3D printing process to achieve overall higher quality outcomes in investment casting. The process will be officially presented at the 64th Technical Conference and Equipment Expo, taking place in Covington, KY, USA from October 15th to 18th , 2017.

This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171005005441/en/

Higher resolution

The new PPC2 is a modified version of the existing PolyPor PMMA processes, offered by voxeljet, which are primarily used to create investment casting patterns. Compared to the existing PMMA processes, models that are printed using PPC2 have an overall increased resolution.

The improved surface quality and clearer edges on the parts are related to a finer PMMA particulate material of 37 μm (0,037 mm), which enables printing at a reduced layer thickness of 100 μm.

A combination of a high definition print head that prints with a resolution of 600 dpi, a reduced grain size and layer thickness, results in very detailed 3D printed models that are ideal for investment casting patterns. The material set causes almost no residual ash.

Economical, productive, and recyclable

Dr. Ingo Ederer, Chief Executive Officer of voxeljet, commented: “Our new PPC2 process will be initially offered on our VX200 system. It is an affordable entry into 3D printing for investment casting foundries with an efficient part production for commercial castings such as turbine impellers and turbine blades. Thanks to our binder jetting technology, no additional support structures are needed. By means of this, precious build space can be used most efficiently by building parts stacked on top of each other”.

Tobias Gruen (Product Manager, voxeljet) adds that “by using our new and improved binder, we expect our industrial print heads to have an increased lifetime at a high and consistent printing quality level. Moreover, the unbound PMMA powder can be reused and recycled for forthcoming printing jobs, which ensures efficient material usage”.

Release and samples

voxeljet’s new PPC² process will be officially presented at the ICI 2017, a conference for investment casting held by the Investment Casting Institute in Covington, KY, USA from October 15th to 18th 2017. Currently, benchmark parts of the new PPC² process can be ordered from voxeljet´s HQs in Germany and from voxeljet America in Canton, Michigan.

About voxeljet

voxeljet is a leading provider of high-speed, large-format 3D printers and on-demand parts services to industrial and commercial customers. The Company’s 3D printers employ a powder binding, additive manufacturing technology to produce parts using various material sets, which consist of particulate materials and proprietary chemical binding agents. The Company provides its 3D printers and on-demand parts services to industrial and commercial customers serving the automotive, aerospace, film and entertainment, art and architecture, engineering and consumer product end markets. For more information, visit https://www.voxeljet.com .

Contact:

voxeljet AG
Investors and Media
Johannes Pesch
Director Investor Relations and Business Development
johannes.pesch@voxeljet.de
Office: +49 821 7483172
Mobile: +49 176 45398316

Link:

ClickThru

Social Media:

https://www.facebook.com/voxeljet

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Intends to Buy Back approximately 2.4 Million Shares in the Context of the Accelerated Bookbuild Offering by EQT, ADIA and Auba27.5.2025 17:46:00 CEST | Press release

Galderma Group AG (SWX:GALD): Ad hoc announcement pursuant to Art. 53 LR Galderma intends to repurchase approximately 2.4 million shares in the context of the accelerated bookbuild offering of Galderma shares by Sunshine SwissCo GmbH (“EQT”), Abu Dhabi Investment Authority (“ADIA”) and Auba Investment Pte. Ltd. (“Auba”) announced today The repurchased shares will be held in treasury and financed by existing liquidity at hand Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that it intends to repurchase approximately 2.4 million Galderma shares in the context of an accelerated bookbuilding offering (“ABO”) of approximately 16.7 million Galderma shares (approximately 7% of Galderma’s share capital) by EQT, ADIA and Auba. Galderma will participate in the ABO at the same price per share which will be determined in the bookbuilding. The repurchased shares will be financed by Galderma’s existing liquidity on hand and will not affect the company’s ability to de

New South Wales Minister for Industry and Trade Visits Novotech Seoul Office to Strengthen Clinical Trial Collaboration27.5.2025 17:44:00 CEST | Press release

Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory company trusted by biotech and small- to mid-sized pharmaceutical companies to guide drug development at every phase, was honored to welcome The Hon. Anoulack Chanthivong, New South Wales (NSW) Minister for Industry and Trade, to its Seoul office on May 19. The Minister’s visit highlights a deepening collaboration between South Korea and Australia in the field of clinical research and highlights the strategic importance of cross-border partnerships in advancing global drug development. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250527294947/en/ Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory company trusted by biotech and small- to mid-sized pharmaceutical companies to guide drug development at every phase, was honored to welcome The Hon. Anoulack Chanthivong,

LambdaTest Introduces Automation MCP Server to Revolutionize Test Failure Triaging27.5.2025 17:00:00 CEST | Press release

~New server connects AI assistants directly to test execution data, streamlining debugging and accelerating development~ LambdaTest, a unified agentic AI and cloud engineering platform, has announced the launch of its Automation MCP Server, a breakthrough solution designed to simplify and accelerate the process of triaging test failures. By enabling direct integration between AI assistants and LambdaTest’s test execution data, the Automation MCP Server empowers developers and QA engineers to investigate and resolve issues faster, without leaving their integrated development environment (IDE). The Automation MCP Server offers a seamless interface within the IDE, allowing users to access and analyze real-time test data with ease. With intelligent root cause analysis, the MCP server can quickly identify the underlying reasons for test failures and take immediate action to fix the underlying code. This results in fewer debugging cycles and faster release times. The server also enhances aut

The Six Winning Projects of the 12th Edition of the IBSA Foundation Fellowships have been Awarded and the 2025 Call is Now Open27.5.2025 16:58:00 CEST | Press release

The winners of the 2024 IBSA Foundation Fellowships Call come from two US, two Swedish, one Italian and one British universities.This year’s edition set a new record: 259 projects submitted from 45 countries.The awards ceremony was held today in Milan; during the event, the 2025 call for applications was officially opened. Research means investing in the future. This is the guiding principle behind the IBSA Foundation Fellowships programme, which for over a decade has supported talented researchers under 40 from universities and research institutions around the world. The programme awards grants to promote innovative and potentially groundbreaking projects in lesser-explored scientific fields; a constantly growing success, also confirmed by the 2024 edition, which marked a new record, with 259 applications across five scientific areas. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250522244202/en/ The Award Ceremony of the

Rigaku Completes New Building at Yamanashi Plant27.5.2025 16:00:00 CEST | Press release

Dramatic 2.7-fold increase in floor space to serve global demand Rigaku Corporation, a global solution partner in X-ray analytical technologies and a Group company of Rigaku Holdings Corporation (headquarters: Akishima, Tokyo; President and CEO: Jun Kawakami; hereinafter “Rigaku”) completed an additional manufacturing building (hereinafter “the New Building”) at Yamanashi Plant, Rigaku’s main production facility. The facility was established to serve as the center of Rigaku’s production framework, in anticipation of global business growth and expansion in product demand. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250527974928/en/ Exterior view of the New Building, Yamanashi Plant Doubling of production capacity: a strategic base to support Rigaku’s growth Demand for X-ray analytical solutions has soared in recent years, both in Japan and worldwide. To respond to growing demand, Rigaku implemented this expansion with two

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye